Protagenic Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 30.83% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.5%	Garo Armen	738,489	US$449.0k	0.57%	no data
5.37%	Armistice Capital LLC	240,000	US$145.9k	0%	no data
3.38%	Khalil Barrage	150,880	US$91.7k	0%	no data
1.03%	Alexander Arrow	45,815	US$27.9k	0%	no data
0.92%	Citadel Advisors LLC	40,909	US$24.9k	0%	no data
0.83%	David Lovejoy	37,200	US$22.6k	0%	no data
0.74%	The Vanguard Group, Inc.	33,166	US$20.2k	0%	no data
0.58%	Geode Capital Management, LLC	26,054	US$15.8k	-10.6%	no data
0.48%	Osaic Wealth, Inc. , Asset Management Arm	21,414	US$13.0k	0%	no data
0.31%	State Street Global Advisors, Inc.	13,812	US$8.4k	0%	no data
0.29%	Virtu Financial LLC, Asset Management Arm	13,118	US$8.0k	0%	no data
0.22%	UBS Asset Management AG	9,740	US$5.9k	-3.35%	no data
0.15%	Tower Research Capital Europe Limited	6,829	US$4.2k	0.34%	no data
0.00092%	Bank of America Corporation, Asset Management Arm	41	US$25.0	41.4%	no data
0.00002%	Carson Wealth Management Group	1	US$0.5	0%	no data
0.00002%	Morgan Stanley, Investment Banking and Brokerage Investments	1	US$0.5	0%	no data